InspireMD Stock Price - NSPR

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 1.16 ▼ -0.03 (-2.52%)
Company Name Stock Ticker Symbol Market Type
InspireMD Inc New NSPR AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0454 3.97% 1.19 1.20 1.13 1.19 1.1446 18:26:10
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
311 67,905 $ 1.17 $ 79,725 387,860 1.11 - 13.60
Last Trade Time Type Quantity Stock Price Currency
18:30:00 1,400 $ 1.19 USD

InspireMD Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.31M 1.94M $ -7.24M -64.66 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
96.58k $ - 0.00% 3.18M -

more financials information »

InspireMD News

Loading Messages....

Latest NSPR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NSPR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.321.411.111.25106,527-0.13-9.85%
1 Month1.361.411.111.27153,057-0.17-12.5%
3 Months3.115.301.112.11251,217-1.92-61.74%
6 Months4.327.511.113.49220,821-3.13-72.45%
1 Year11.0013.601.118.62721,462-9.81-89.18%
3 Years3,115.007,682.501.11345.101,647,255-3,113.81-99.96%
5 Years13,685.592692,750.001.111,531.731,249,617-13,684.40-99.99%

InspireMD Description

InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.


Your Recent History
AMEX
NSPR
InspireMD
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.